Michael Pirovolakis is 18 months old and suffers from a rare genetic disorder. There is a promise of a therapy that may work, but it will cost at least $3 million to do a clinical trial to see if it does.
Welcome to The National, the flagship nightly newscast of CBC News
»»» Subscribe to The National to watch more videos here: https://www.youtube.com/user/CBCTheNational?sub_confirmation=1
Voice Your Opinion & Connect With Us Online:
The National Updates on Facebook: https://www.facebook.com/thenational
The National Updates on Twitter: https://twitter.com/CBCTheNational
»»» »»» »»» »»» »»»
The National is CBC Television’s flagship news program. Airing six days a week, the show delivers news, feature documentaries and analysis from some of Canada’s leading journalists.